Search research articles
Contact Us
Filters
Showing results (11-20 of 97) with videos related to
Page
of 10
Sort By:
The Journal of Biological Chemistry
|
March 19, 2010
The partial replacement of dietary phenylalanine by tyrosine for purposes of growth
M WOMACK, W C ROSE
The Journal of Biological Chemistry
|
March 19, 2010
The utilization of the optical isomers of phenylalanine, and the phenylalanine requirement for growth
W C ROSE, M WOMACK
Biographical Memoirs. National Academy of Sciences (U.S.)
|
January 1, 1974
Howard Bishop Lewis
W C Rose, M J Coon
Anticancer Research
|
January 1, 1992
Transforming growth factor beta 1: lack of in vivo antitumor activity on A549 and Wehi 3BD+ tumors
S P Robinson, W C Rose
The American Journal of Physiology
|
November 1, 1993
Two-port analysis of systemic venous and arterial impedances
W C Rose, A A Shoukas
Cancer Treatment Reviews
|
September 1, 1985
Preclinical antitumor and toxicologic profile of carboplatin
W C Rose, J E Schurig
In Vivo (Athens, Greece)
|
July 1, 1989
An in vivo human tumor xenograft model of etoposide resistance
W C Rose, G A Basler
In Vivo (Athens, Greece)
|
September 1, 1989
Development of a human xenograft model for the evaluation of monoclonal antibody L6-mitomycin immunoconjugates
P A Trail, W C Rose
The American Journal of Physiology
|
August 1, 1996
Analysis of heart rate-based control of arterial blood pressure
W C Rose, J S Schwaber
In Vivo (Athens, Greece)
|
November 1, 1990
In vivo model development of cisplatin-resistant and -sensitive A2780 human ovarian carcinomas
W C Rose, G A Basler
Page
of 10
Search research articles
Search
Showing results (11-20 of 97) with videos related to
Sort By:
Page
of 10
The Journal of Biological Chemistry
|
March 19, 2010
The partial replacement of dietary phenylalanine by tyrosine for purposes of growth
M WOMACK, W C ROSE
The Journal of Biological Chemistry
|
March 19, 2010
The utilization of the optical isomers of phenylalanine, and the phenylalanine requirement for growth
W C ROSE, M WOMACK
Biographical Memoirs. National Academy of Sciences (U.S.)
|
January 1, 1974
Howard Bishop Lewis
W C Rose, M J Coon
Anticancer Research
|
January 1, 1992
Transforming growth factor beta 1: lack of in vivo antitumor activity on A549 and Wehi 3BD+ tumors
S P Robinson, W C Rose
The American Journal of Physiology
|
November 1, 1993
Two-port analysis of systemic venous and arterial impedances
W C Rose, A A Shoukas
Cancer Treatment Reviews
|
September 1, 1985
Preclinical antitumor and toxicologic profile of carboplatin
W C Rose, J E Schurig
In Vivo (Athens, Greece)
|
July 1, 1989
An in vivo human tumor xenograft model of etoposide resistance
W C Rose, G A Basler
In Vivo (Athens, Greece)
|
September 1, 1989
Development of a human xenograft model for the evaluation of monoclonal antibody L6-mitomycin immunoconjugates
P A Trail, W C Rose
The American Journal of Physiology
|
August 1, 1996
Analysis of heart rate-based control of arterial blood pressure
W C Rose, J S Schwaber
In Vivo (Athens, Greece)
|
November 1, 1990
In vivo model development of cisplatin-resistant and -sensitive A2780 human ovarian carcinomas
W C Rose, G A Basler
Page
of 10